ID: ALA5267719

Max Phase: Preclinical

Molecular Formula: C16H18N2O2

Molecular Weight: 270.33

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)n(C)c2cc(N3CCCCC3=O)ccc12

Standard InChI:  InChI=1S/C16H18N2O2/c1-11-9-16(20)17(2)14-10-12(6-7-13(11)14)18-8-4-3-5-15(18)19/h6-7,9-10H,3-5,8H2,1-2H3

Standard InChI Key:  TVJZEYRKRPKMHK-UHFFFAOYSA-N

Associated Targets(Human)

Bromodomain-containing protein 9 684 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.33Molecular Weight (Monoisotopic): 270.1368AlogP: 2.36#Rotatable Bonds: 1
Polar Surface Area: 42.31Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 1.53CX LogD: 1.53
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.80Np Likeness Score: -1.06

References

1. Vaidergorn MM, da Silva Emery F, Ganesan A..  (2021)  From Hit Seeking to Magic Bullets: The Successful Union of Epigenetic and Fragment Based Drug Discovery (EPIDD + FBDD).,  64  (19.0): [PMID:34591474] [10.1021/acs.jmedchem.1c00787]

Source